Assessing outcomes in palliative chemotherapy

Alternate title: 
J2 - Expert Opin Pharmacother
Secondary title: 
T2 - Expert Opinion on Pharmacotherapy
Short title: 
Assessing outcomes in palliative chemotherapy
Authors: 
Cattell, Emma
Arance, Ana
Middleton, Mark
Volume: 
3
Start page: 
693-700
Annotations: 
Type E, research
Date: 
Jun
Year: 
2002
Accession number: 
12036408
Database: 
MEDLINE RCTs
Number: 
M1 - 6
Serial: 
1465-6566
Type of work: 
M3 - Review
ID: 
7082
Notes: 
N1 - Cattell E
Arance A
Middleton M
Key words: 
Antineoplastic Agents/ec [Economics]
*Antineoplastic Agents/tu [Therapeutic Use]
Carcinoma, Non-Small-Cell Lung/dt [Drug Therapy]
Clinical Trials as Topic
Cost-Benefit Analysis
Female
Humans
Lung Neoplasms/dt [Drug Therapy]
Male
Palliative Care/ec [Economics]
*Palliative Care
Pancreatic Neoplasms/dt [Drug Therapy]
Prostatic Neoplasms/dt [Drug Therapy]
Quality of Life
Treatment Outcome
0 (Antineoplastic Agents)
Types of evidence: 
Type E
Other annotations: 
Research